Impact of pembrolizumab on ovarian function in young triple-negative breast cancer patients treated with chemo-immunotherapy

Related articles

1. Effects of neoadjuvant chemotherapy on prognosis and platinum resistance of advanced ovarian cancer

   This article has 6 authors:

   1. Weishan Li
   2. Jia Liu
   3. Peng Chen
   4. Zhihui Liu
   5. Danbo Wang
   6. Zhuo Yang

2. Outcomes of capecitabine plus temozolomide combination therapy in patients with advanced or metastatic pancreatic neuroendocrine tumors: a retrospective observational single-center study

   This article has 15 authors:

   1. Yukiko Hibino
   2. Susumu Hijioka
   3. Chigusa Morizane
   4. Daiki Agarie
   5. Kohei Okamoto
   6. Daiki Yamashige
   7. Shin Yagi
   8. Soma Fukuda
   9. Masaru Kuwada
   10. Yasuhiro Komori
   11. Mao Okada
   12. Yuta Maruki
   13. Yoshikuni Nagashio
   14. Hideki Ueno
   15. Takuji Okusaka

3. The Prognostic and Predictive Roles of Ataxia–Telangiectasia Mutated (ATM) Expression in Patients with Metastatic Non-Small-Cell Lung Cancer Receiving Pembrolizumab Monotherapy Alone or in Combination with Chemotherapy

   This article has 8 authors:

   1. Jamshid Hamdard
   2. Harun Muğlu
   3. Ahmet Bilici
   4. Elif Kuzucular
   5. Özgür Açıkgöz
   6. Ömer Fatih Ölmez
   7. Oktay Olmuşçelik
   8. Özcan Yıldız